Top Markets
Coin of the day
Pharmosa Biopharm Inc. Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.

6875
Rangering i aksjer #20403
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Aksjekurs
$1.02
Markedsverdi
$131.45M
Endring (1 dag)
-0.62%
Endring (1 år)
-37.92%
Land
TW
Handel Pharmosa Biopharm Inc. (6875)

Kategori

Aksjeprishistorikk for Pharmosa Biopharm Inc. (6875)
Høyeste sluttskurs: $1.04 den 2026-08-01

Laveste sluttskurs: $1.60 den 2022-02-01
Aksjeprishistorikk for Pharmosa Biopharm Inc. fra 2022 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -19.43%
2025 1.72%
2024 -40.77%
2023 55.60%
2022 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.27 -15.19%
AU
$764.21 8.13%
CH